Plasma and serum are accessible sample types; however, the high dynamic range of proteins creates analytical challenges for the sensitive detection of potential biomarkers. Two approaches have advanced our capabilities for measuring biomarkers in these complex biofluids.
![](https://dls.com/wp-content/uploads/2024/04/AACR-2024-Cancer-Biomarker-Discovery-with-Scalable-Biofluid-Proteomics-Thumbnail.jpg)